DK175529B1 - Intravaginal indretning - Google Patents

Intravaginal indretning Download PDF

Info

Publication number
DK175529B1
DK175529B1 DK198703034A DK303487A DK175529B1 DK 175529 B1 DK175529 B1 DK 175529B1 DK 198703034 A DK198703034 A DK 198703034A DK 303487 A DK303487 A DK 303487A DK 175529 B1 DK175529 B1 DK 175529B1
Authority
DK
Denmark
Prior art keywords
estradiol
elastomer
approx
hours
core
Prior art date
Application number
DK198703034A
Other languages
Danish (da)
English (en)
Other versions
DK303487D0 (da
DK303487A (da
Inventor
Inga Marianne Lindskog
Bengt Christer Hans Sjoegren
Sven-Boerje Andersson
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of DK303487D0 publication Critical patent/DK303487D0/da
Publication of DK303487A publication Critical patent/DK303487A/da
Application granted granted Critical
Publication of DK175529B1 publication Critical patent/DK175529B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Paper (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Window Of Vehicle (AREA)
  • Seal Device For Vehicle (AREA)
  • Steroid Compounds (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DK198703034A 1986-06-16 1987-06-15 Intravaginal indretning DK175529B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8602666A SE8602666D0 (sv) 1986-06-16 1986-06-16 Intravaginal devices
SE8602666 1986-06-16

Publications (3)

Publication Number Publication Date
DK303487D0 DK303487D0 (da) 1987-06-15
DK303487A DK303487A (da) 1987-12-17
DK175529B1 true DK175529B1 (da) 2004-11-22

Family

ID=20364821

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703034A DK175529B1 (da) 1986-06-16 1987-06-15 Intravaginal indretning

Country Status (22)

Country Link
US (1) US4871543A (sv)
EP (1) EP0253109B1 (sv)
JP (1) JP2671953B2 (sv)
KR (1) KR920005824B1 (sv)
CN (1) CN1034391C (sv)
AT (1) ATE68097T1 (sv)
AU (1) AU599988B2 (sv)
CA (1) CA1314482C (sv)
DE (1) DE3773557D1 (sv)
DK (1) DK175529B1 (sv)
ES (1) ES2026481T3 (sv)
FI (1) FI91709C (sv)
GR (1) GR3003551T3 (sv)
HU (1) HU205014B (sv)
IE (1) IE60654B1 (sv)
IL (1) IL82769A (sv)
NO (2) NO172784C (sv)
NZ (1) NZ220616A (sv)
PH (1) PH26981A (sv)
PT (1) PT85082B (sv)
SE (1) SE8602666D0 (sv)
ZA (1) ZA874174B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
FI95768C (sv) * 1993-06-17 1996-03-25 Leiras Oy Intravaginalt doseringssystem
FI93922C (sv) * 1993-06-17 1995-06-26 Leiras Oy Anordning för avgivande av verksamt ämne
IL116433A (en) * 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US6030375A (en) * 1996-03-29 2000-02-29 Iotek, Inc. Compressible vaginal insert and method for treating urogenital disorders
US5816248A (en) * 1996-03-29 1998-10-06 Iotek, Inc. Channeled vaginal insert and method for treating urogenital disorders
US5988169A (en) * 1996-03-29 1999-11-23 Iotek, Inc. Vaginal insert and method for treating urogenital disorders
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen
CN1652798A (zh) * 2002-03-11 2005-08-10 詹森药业有限公司 连续抑制硫酸酯酶的孕激素的激素替代疗法
US20030219471A1 (en) * 2002-03-11 2003-11-27 Caubel Patrick Michel Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
EP1482949A1 (en) * 2002-03-11 2004-12-08 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US7816546B2 (en) * 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
JP5507467B2 (ja) * 2008-02-04 2014-05-28 テバ ウィメンズ ヘルス インコーポレイテッド プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用
EP4069248A4 (en) 2019-12-06 2024-01-03 Prathima Chowdary SUSTAINED RELEASE VAGINAL RING PESSARY FOR TREATMENT OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSUS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
IN142428B (sv) * 1974-07-05 1977-07-09 Schering Ag
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
DE2450107A1 (de) * 1974-10-18 1976-04-29 Schering Ag Vaginalring
DE2611535A1 (de) * 1976-03-16 1977-09-29 Schering Ag 6alpha-hydroxy-8alpha-oestradiole
JPS5845440B2 (ja) * 1978-08-29 1983-10-08 呉羽化学工業株式会社 プロスタグランジン誘導体とその製造方法及び薬剤
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) * 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
US4402695A (en) * 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
DE3405227A1 (de) * 1983-02-22 1984-08-23 Joachim Georg Bellaire Tex. Liehr Verbesserung in bezug auf die behandlung von oestrogenmangelzustaenden
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances

Also Published As

Publication number Publication date
JPS62298532A (ja) 1987-12-25
NO872489L (no) 1987-12-17
IE60654B1 (en) 1994-08-10
EP0253109B1 (en) 1991-10-09
EP0253109A1 (en) 1988-01-20
FI872629A (sv) 1987-12-17
AU599988B2 (en) 1990-08-02
NO172784C (no) 1993-09-08
IL82769A0 (en) 1987-12-20
PT85082A (en) 1987-07-01
US4871543A (en) 1989-10-03
ES2026481T3 (es) 1992-05-01
DK303487D0 (da) 1987-06-15
CN87104229A (zh) 1987-12-30
FI91709B (sv) 1994-04-29
DK303487A (da) 1987-12-17
IE871377L (en) 1987-12-16
ZA874174B (en) 1987-12-11
KR920005824B1 (ko) 1992-07-20
KR880000114A (ko) 1988-03-23
IL82769A (en) 1991-07-18
GR3003551T3 (sv) 1993-03-16
NZ220616A (en) 1990-09-26
CN1034391C (zh) 1997-04-02
JP2671953B2 (ja) 1997-11-05
NO172784B (no) 1993-06-01
CA1314482C (en) 1993-03-16
FI872629A0 (sv) 1987-06-12
NO872489D0 (no) 1987-06-15
FI91709C (sv) 1994-08-10
SE8602666D0 (sv) 1986-06-16
ATE68097T1 (de) 1991-10-15
PH26981A (en) 1992-12-28
AU7422287A (en) 1987-12-17
NO1997001I1 (no) 1997-01-13
PT85082B (pt) 1990-03-08
DE3773557D1 (de) 1991-11-14
HUT44931A (en) 1988-05-30
HU205014B (en) 1992-03-30

Similar Documents

Publication Publication Date Title
DK175529B1 (da) Intravaginal indretning
US5188835A (en) Intravaginal devices
JP3806197B2 (ja) 腟内薬剤放出器具
FI119414B (sv) Intravaginala läkemedelstillförselsanordningar för givande av 17beta-estradiolprekursorer
AU618052B2 (en) Topical preparations containing danazol
CA2448273C (en) Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
JP2001524124A (ja) テストステロンおよびテストステロン前駆体の投与のための膣内薬物送達用具
Jackanicz Levonorgestrel and estradiol release from an improved contraceptive vaginal ring
Dericks-Tan et al. Elevation of serum prolactin during application of oral contraceptives
Olsson et al. Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol
US20040142914A1 (en) Extended transdermal contraceptive regimens
Victor et al. Vaginal progesterone for contraception
EP1613293A1 (en) Extended transdermal contraceptive regimens
Timmer et al. Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel: Cerazette® and Liseta®
Ibarra de Palacios et al. Comparative study to evaluate skin irritation and adhesion of Estradot® and Climara® in healthy postmenopausal women
WO2012121811A1 (en) Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibronlytic or hemostatic agent
JPH05500207A (ja) 避妊を行う組成物および方法
Gupta et al. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study
Jaschevatzky et al. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol
Runnebaum et al. Trends in hormonal contraception
Nash et al. Patent: Intravaginal ring

Legal Events

Date Code Title Description
PUP Patent expired